Gainers
- Aravive ARAV shares rose 67.5% to $0.24 during Friday's regular session. As of 13:30 EST, this security is trading at a volume of 90.0 million shares, making up 979.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $17.3 million.
- Lipella Pharmaceuticals LIPO stock moved upwards by 42.27% to $2.29. Lipella Pharmaceuticals's stock is trading at a volume of 39.3 million shares as of 13:30 EST. This is 574673.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $13.2 million.
- Sagimet Biosciences SGMT shares rose 25.27% to $5.72. As of 13:30 EST, this security is trading at a volume of 70.1K shares, making up 54.7% of its average full-day volume over the last 100 days. The company's market cap stands at $130.9 million.
- Catalyst Biosciences CBIO shares increased by 23.16% to $0.49. Catalyst Biosciences's stock is trading at a volume of 2.6 million shares as of 13:30 EST. This is 717.8% of its average full-day volume over the last 100 days. The company's market cap stands at $18.7 million.
- Redhill Biopharma RDHL shares rose 20.78% to $0.53. Trading volume for Redhill Biopharma's stock is 1.3 million as of 13:30 EST. This is 89.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.1 million.
- Eiger BioPharmaceuticals EIGR stock rose 17.38% to $0.32. The current volume of 117.0K shares is 39.3% of Eiger BioPharmaceuticals's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $14.1 million.
Losers
- Processa Pharma PCSA stock fell 32.4% to $0.36 during Friday's regular session. As of 13:30 EST, this security is trading at a volume of 2.8 million shares, making up 157.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $8.9 million.
- Atreca BCEL stock declined by 25.7% to $0.27. Atreca's stock is trading at a volume of 2.3 million shares as of 13:30 EST. This is 140.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $10.7 million.
- RVL Pharmaceuticals RVLP shares declined by 25.55% to $0.03. Trading volume for RVL Pharmaceuticals's stock is 38.3 million as of 13:30 EST. This is 180.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.4 million.
- Adial Pharmaceuticals ADIL stock declined by 22.35% to $2.19. The market value of their outstanding shares is at $2.6 million.
- Renovaro Biosciences RENB stock decreased by 20.87% to $2.73. Renovaro Biosciences's stock is trading at a volume of 397.0K shares as of 13:30 EST. This is 38.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $179.3 million.
- Outlook Therapeutics OTLK shares decreased by 20.0% to $0.53. As of 13:30 EST, Outlook Therapeutics's stock is trading at a volume of 18.1 million, which is 213.9% of its average full-day volume over the last 100 days. The company's market cap stands at $137.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in